Objectives: 10 patients underwent a single treatment session, with one facial side receiving fractional CO₂ alone and the contralateral side treated using a sequential emission of 1570 nm laser energy immediately following each CO₂-created microchannel. At 12 weeks post-treatment, blinded evaluators using the Goodman and Baron scales observed an average of 18% greater clinical improvement on the sequential side (p < 0.05). Patients also reported higher satisfaction scores for the dual-wavelength side, with no significant difference in pain, adverse events, or downtime

Objectives: Attendees will explore the world’s first clinical application of amniotic-derived exosomes (EXOCLEO), characterized by young cellular origin and low immunogenicity. This session presents clinical evidence of accelerated healing, reduced inflammation, and enhanced skin rejuvenation following microneedling and fractional laser in active acne and acne scars. Participants will understand optimized regenerative protocols for faster, safer recovery.